Wyatt Cameron Tran

Wyatt Cameron Tran

Auto-generated profile, based on publicly available information

Wyatt Cameron Tran

Department of Microbiology, University of Massachusetts , Amherst, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2025 in Nature
Verified
Journal Article
Open access
PDF file
GSGuangbin Shi
Guangbin Shi
CMClaire Miller
Claire Miller
SKSota Kuno
Sota Kuno
AHAlejandro G. Rey Hipolito
Alejandro G. Rey Hipolito
SNSalsabiel El Nagar
Salsabiel El Nagar
MPMichael E. Pacold
Michael E. Pacold
Decreased brain levels of coenzyme Q10 (CoQ10), an endogenously synthesized lipophilic antioxidant1,2, underpin encephalopathy in primary CoQ10 deficiencies3,4 and are associated with common neurodegenerative diseases and the ageing process5,6. CoQ10 supplementation does not increase CoQ10 pools in the brain or in other tissues. The recent discovery of the mammalian CoQ10 headgroup synthesis pathway, in which 4-hydroxyphenylpyruvate dioxygenase-like protein (HPDL) makes 4-hydroxymandelate (4-HMA) to synthesize the CoQ10 headgroup precursor 4-hydroxybenzoate (4-HB)7, offers an opportunity to pharmacologically restore CoQ10 synthesis and mechanistically treat CoQ10 deficiencies. To test whether 4-HMA or 4-HB supplementation promotes CoQ10 headgroup synthesis in vivo, here we administered 4-HMA and 4-HB to Hpdl−/− mice, which model an ultra-rare, lethal mitochondrial encephalopathy in humans. Both 4-HMA and 4-HB were incorporated into CoQ9 and CoQ10 in the brains of Hpdl−/− mice. Oral treatment of Hpdl−/− pups with 4-HMA or 4-HB enabled 90–100% of Hpdl−/− mice to live to adulthood. Furthermore, 4-HB treatment stabilized and improved the neurological symptoms of a patient with progressive spasticity due to biallelic HPDL variants. Our work shows that 4-HMA and 4-HB can modify the course of mitochondrial encephalopathy driven by HPDL variants and demonstrates that CoQ10 headgroup intermediates can restore CoQ10 synthesis in vivo.

14 November 2025 in Science Advances
Verified
Journal Article
Open access
VCVeronica Costiniti
Veronica Costiniti
WTWyatt C. Tran
Wyatt C. Tran
NBNandhini Rajesh Babu
Nandhini Rajesh Babu
EKEvgeny Kanshin
Evgeny Kanshin
BUBeatrix Ueberheide
Beatrix Ueberheide
RBRobert S. Banh
Robert S. Banh
Differential mRNA translation efficiency (mTE) of codons is important in regulating protein synthesis and cellular states and can change in response to amino acid availability. While the mTE of codons is canonically associated with their corresponding transfer RNA (tRNA) isoacceptors, its regulation by amino acids in mammalian cells remains unexplored. We found that ELAC2, a 3′ tRNA maturation endonuclease, decreases the mTE of UC[C/U] serine (Ser) codons in response to Ser limitation. Ablation of ELAC2 restored UC[C/U] mTE but reduced the mTE of AG[U/C] Ser codons. Among the tRNA Ser isoacceptors, tRNA Ser(GCU) decreased the most in ELAC2 -deficient cells. Unexpectedly, tRNA Ser(GCU) delivery restored AG[U/C] mTE and reduced UC[C/U] mTE in ELAC2 -deficient cells. Last, we deciphered the effects of Ser-sensitive codons on mRNA translation and the human proteome. Our study revealed that in response to Ser limitation, regulation of tRNA Ser(GCU) levels fine-tune the mTE of UC[C/U] or AG[U/C] Ser-sensitive codons and shapes the proteome.

16 November 2023 in Microbiology Resource Announcements
Verified
Journal Article
Open access
BSBrendan Sullivan
Brendan Sullivan
CKClaire E. Kitzmiller
Claire E. Kitzmiller
WTWyatt C. Tran
Wyatt C. Tran
MCMallory Choudoir
Mallory Choudoir
RSRachel Simoes
Rachel Simoes
KDKristen M Deangelis
Kristen M Deangelis
The complete genome sequence of Bacillus thuringiensis strain RC340, isolated from an environmental microbiology experiment soil sample is presented here. B. thuringiensis strain RC340 sequenced by GridION consists of a single genome consisting of 5.86 million bases, 8,152 predicted genes, and 0.23% contamination.

11 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
VCVeronica Costiniti
Veronica Costiniti
MKMegan Korn
Megan Korn
WTWyatt Cameron Tran
Wyatt Cameron Tran
NBNandhini Rajesh Babu
Nandhini Rajesh Babu
ASAlbert Sohn
Albert Sohn
RBRobert S. Banh
Robert S. Banh
Neoantigen-based cancer immunotherapy is a promising approach that enables highly specific targeting of cancer cells through different biological tools and minimizing damage to healthy tissues. Despite this advantage, neoantigen therapies face significant challenges which can limit tumor immunogenicity, such as tumor heterogeneity, variable mutation rates, and immune evasion through loss or downregulation of antigen presentation. Pancreatic ductal adenocarcinoma (PDAC) is considered one of the most resistant tumors to immunotherapy in part due to its relatively low mutational burden, which results in poor neoantigen presentation and weak immune responses. However, several studies have demonstrated that PDAC patients with higher immunogenicity exhibit improved survival. In this work we show that systemic neoantigen production can be induced in PDAC and other cancers by leveraging the tumor microenvironment, specifically by tuning amino acid availability. By engineering new tools to monitor and target phenylalanine-to-tyrosine (FtY) substitutions in vitro and in vivo, we demonstrate that FtY mistranslational errors in PDAC can be modulated by altering the balance between phenylalanine (Phe) and tyrosine (Tyr). We demonstrated that FtY misincorporation reshapes the cancer cell proteome, generating new classes of targetable FtY neoantigens, including cell surface proteins (e.g. MHC) or immunopeptides. To induce FtY errors in PDAC tumors, mice were treated with nitisinone (an FDA approved HPD inhibitor) to increase Tyr levels. We found that Tyr elevation in vivo combined with immune checkpoint blockade (ICB), reduces tumor burden by enhanced T-cell cytotoxicity. Our findings reveal an anti-tumor therapeutic strategy that turns the translational error of FtY misincorporation into a targeted vulnerability.

19 September 2023 in Microbiology Resource Announcements
Verified
Journal Article
Open access
CKClaire E. Kitzmiller
Claire E. Kitzmiller
WTWyatt C. Tran
Wyatt C. Tran
BSBrendan Sullivan
Brendan Sullivan
FCFlorencia Cortez
Florencia Cortez
MCMallory Choudoir
Mallory Choudoir
KDKristen M Deangelis
Kristen M Deangelis
Paenibacillus spp. RC334 and RC343 were isolated from heated soil in a long-term soil warming experiment. Both genomes were 5.98 Mb and assembled as a single contig. We describe the assembly and annotation of the two high-quality draft genomes for these isolates here.

16 November 2023 in Microbiology Resource Announcements
Verified
Journal Article
Open access
WTWyatt C. Tran
Wyatt C. Tran
BSBrendan Sullivan
Brendan Sullivan
CKClaire E. Kitzmiller
Claire E. Kitzmiller
MCMallory Choudoir
Mallory Choudoir
RSRachel Simoes
Rachel Simoes
KDKristen M Deangelis
Kristen M Deangelis
Paenibacillus sp. strain RC67 was isolated from the Harvard Forest long-term soil warming experiment. The assembled genome is a single contig with 7,963,753 bp and 99.4% completion. Genome annotation suggests that the isolate is of a novel bacterial species.